SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : World Heart Corp - WHRT and TSE/WHT
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dan Hamilton who wrote (439)6/13/2000 2:30:00 PM
From: William Marsh  Read Replies (2) of 500
 
A different point of view.

It seems to me that WHT is claiming that, it exchange for a three month delay, they get:
1. More cash.
2. An established product line.
3. An established distribution channel.
4. A significant improvement to their lead product (the blood bag).
5. A simpler pathway to regulatory approval (due to the approved status of the blood bag).
6. Elimination of a competitor.

All these benefits are verifiable (if not verified). To me,
this seems to be a pretty strong case.

Bill
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News